Gilead Hepatitis C Drug Highly Effective in Cirrhosis Patients

Share this content:
Gilead hepatitis C drug highly effective in cirrhosis patients
Gilead hepatitis C drug highly effective in cirrhosis patients
The Gilead study involved 155 patients with cirrhosis and the most common genotype 1 form of the liver virus. They previously had failed to benefit from standard older treatments that included protease inhibitors as well as interferon and ribavirin, drugs that can cause harsh side effects and must be taken for almost a year.
READ FULL ARTICLE From Reuters
Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

is free, fast, and customized just for you!




Already a member?

Sign In Now »